GTR 108610165
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Agreements For Medicines Containing The Active Ingredient Fremanezumab (Atc Code: N02cd03) Through An Open House Model
ICB — International Competitive Bid
Closes Mar 31, 2028
Western Europe
Tender Information
GTR Reference
108610165
Tendering Authority
Subscribe to view
Tender No
88189-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Agreements For Medicines Containing The Active Ingredient Fremanezumab (Atc Code: N02cd03) Through An Open House Model
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-03-2028
Work Detail
Pharmaceutical Products – Conclusion Of Non-Exclusive Agreements For Medicines Containing The Active Ingredient Fremanezumab (Atc Code: N02cd03) Through An Open House Model. See Short Description
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
8b92a190-6368-407c-8cc7-d3ac372d6e3d.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.